Current status of neuroprotection trials for traumatic brain injury: Lessons from animal models and clinical studies

Ross Bullock, Bruce G. Lyeth, J. Paul Muizelaar

Research output: Contribution to journalArticle

142 Citations (Scopus)

Abstract

LABORATORY STUDIES HAVE identified numerous potential therapeutic interventions that might have clinical application for the treatment of human traumatic brain injury. Many of these therapies have progressed into human clinical trials in severe traumatic brain injury. Numerous trials have been completed, and many others have been prematurely terminated or are currently in various phases of testing. The results of the completed Phase III trials have been generally disappointing, compared with the expectations produced by the successes of these interventions in animal laboratory studies. In this review, we summarize the current status of human traumatic brain injury clinical trials, as well as the animal laboratory studies that led to some of these trials. We summarize criteria for conducting clinical trials in severe traumatic brain injury, with suggestions for future improvements. We also attempt to identify factors that might contribute to the discrepancies between animal and human trials, and we propose recommendations that could help investigators avoid certain pitfalls in future clinical trials in traumatic brain injury.

Original languageEnglish
Pages (from-to)207-220
Number of pages14
JournalNeurosurgery
Volume45
Issue number2
DOIs
StatePublished - Aug 1 1999
Externally publishedYes

Fingerprint

Animal Models
Clinical Trials
Laboratory Animals
Research Personnel
Traumatic Brain Injury
Neuroprotection
Clinical Studies
Therapeutics

Keywords

  • Animal models
  • Clinical trials
  • Glasgow Outcome Scale
  • Neuroprotection
  • Therapy
  • Traumatic brain injury

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Current status of neuroprotection trials for traumatic brain injury : Lessons from animal models and clinical studies. / Bullock, Ross; Lyeth, Bruce G.; Muizelaar, J. Paul.

In: Neurosurgery, Vol. 45, No. 2, 01.08.1999, p. 207-220.

Research output: Contribution to journalArticle

Bullock, Ross ; Lyeth, Bruce G. ; Muizelaar, J. Paul. / Current status of neuroprotection trials for traumatic brain injury : Lessons from animal models and clinical studies. In: Neurosurgery. 1999 ; Vol. 45, No. 2. pp. 207-220.
@article{b4659981c7994790b7f99296052742c3,
title = "Current status of neuroprotection trials for traumatic brain injury: Lessons from animal models and clinical studies",
abstract = "LABORATORY STUDIES HAVE identified numerous potential therapeutic interventions that might have clinical application for the treatment of human traumatic brain injury. Many of these therapies have progressed into human clinical trials in severe traumatic brain injury. Numerous trials have been completed, and many others have been prematurely terminated or are currently in various phases of testing. The results of the completed Phase III trials have been generally disappointing, compared with the expectations produced by the successes of these interventions in animal laboratory studies. In this review, we summarize the current status of human traumatic brain injury clinical trials, as well as the animal laboratory studies that led to some of these trials. We summarize criteria for conducting clinical trials in severe traumatic brain injury, with suggestions for future improvements. We also attempt to identify factors that might contribute to the discrepancies between animal and human trials, and we propose recommendations that could help investigators avoid certain pitfalls in future clinical trials in traumatic brain injury.",
keywords = "Animal models, Clinical trials, Glasgow Outcome Scale, Neuroprotection, Therapy, Traumatic brain injury",
author = "Ross Bullock and Lyeth, {Bruce G.} and Muizelaar, {J. Paul}",
year = "1999",
month = "8",
day = "1",
doi = "10.1097/00006123-199908000-00001",
language = "English",
volume = "45",
pages = "207--220",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Current status of neuroprotection trials for traumatic brain injury

T2 - Lessons from animal models and clinical studies

AU - Bullock, Ross

AU - Lyeth, Bruce G.

AU - Muizelaar, J. Paul

PY - 1999/8/1

Y1 - 1999/8/1

N2 - LABORATORY STUDIES HAVE identified numerous potential therapeutic interventions that might have clinical application for the treatment of human traumatic brain injury. Many of these therapies have progressed into human clinical trials in severe traumatic brain injury. Numerous trials have been completed, and many others have been prematurely terminated or are currently in various phases of testing. The results of the completed Phase III trials have been generally disappointing, compared with the expectations produced by the successes of these interventions in animal laboratory studies. In this review, we summarize the current status of human traumatic brain injury clinical trials, as well as the animal laboratory studies that led to some of these trials. We summarize criteria for conducting clinical trials in severe traumatic brain injury, with suggestions for future improvements. We also attempt to identify factors that might contribute to the discrepancies between animal and human trials, and we propose recommendations that could help investigators avoid certain pitfalls in future clinical trials in traumatic brain injury.

AB - LABORATORY STUDIES HAVE identified numerous potential therapeutic interventions that might have clinical application for the treatment of human traumatic brain injury. Many of these therapies have progressed into human clinical trials in severe traumatic brain injury. Numerous trials have been completed, and many others have been prematurely terminated or are currently in various phases of testing. The results of the completed Phase III trials have been generally disappointing, compared with the expectations produced by the successes of these interventions in animal laboratory studies. In this review, we summarize the current status of human traumatic brain injury clinical trials, as well as the animal laboratory studies that led to some of these trials. We summarize criteria for conducting clinical trials in severe traumatic brain injury, with suggestions for future improvements. We also attempt to identify factors that might contribute to the discrepancies between animal and human trials, and we propose recommendations that could help investigators avoid certain pitfalls in future clinical trials in traumatic brain injury.

KW - Animal models

KW - Clinical trials

KW - Glasgow Outcome Scale

KW - Neuroprotection

KW - Therapy

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=0032839242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032839242&partnerID=8YFLogxK

U2 - 10.1097/00006123-199908000-00001

DO - 10.1097/00006123-199908000-00001

M3 - Article

C2 - 10449064

AN - SCOPUS:0032839242

VL - 45

SP - 207

EP - 220

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 2

ER -